Market Overview:
The global eye stent market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases, rising awareness about eye care, and technological advancements in the field of ophthalmology. The global eye stent market is segmented on the basis of type, application, and region. On the basis of type, it is divided into polymer and gelatin stents. Polymer stents are further classified into self-expanding polymeric stents (SEPS) and balloon-expandable polymeric stents (BEPs). Gelatin stents are made up of natural collagen extracted from animal skin or bones. They are non-toxic and biocompatible with human tissues; hence they find extensive use in medical implants such as heart valves, bone grafts etc.
Product Definition:
An eye stent is a small mesh tube that's inserted into an artery in the neck and passed through to the brain. It's used to hold open an artery that was narrowed or blocked by a blood clot.
Polymer:
Polymer is a long-chain molecule, which can be crosslinked or non-crosslinked. The most commonly used polymers are Polyethylene (PE), Polypropylene (PP), and Polystyrene (PS). PE is the most widely used polymer in the industry as it has low molecular weight that allows easy penetration through corneal tissue.
Gelatin:
Gelatin is a collagen-based protein that is extracted from the skin, tendons, and bones of animals. It has been used in pharmaceutical formulations for over two centuries owing to its unique properties such as biocompatibility and ability to form hydrogels. Modern extraction techniques have overcome the problems associated with traditional methods of gelatin production such as contamination leading to significant growth in gelatin market volume over the past few years.
Application Insights:
Based on application, the global eye stent market is segmented into eye clinics, eye research institutes and hospitals. Eye clinics held the largest share of over 70% in 2017. The use of stents for treating glaucoma has gained significant popularity among ophthalmologists at eye clinics due to low cost and easy availability. As a result, demand from this segment is expected to remain strong during the forecast period.
The hospital application segment is anticipated to witness growth at a CAGR of XX% from 2018 to 2030 owing to increasing utilization in cataract surgery as well as open-angle glaucoma surgeries. In addition, rising prevalence of diabetes mellitus and other cardiovascular diseases increases the risk factor for glaucoma patients undergoing cataract surgery or those suffering from open-angle glaucomas; thus driving hospital applications over the forecast period with high potentiality.
Regional Analysis:
North America dominated the global eye stent market in 2017 due to the presence of a large number of key players and high adoption rate for advanced technologies. The region is expected to maintain its dominance over the forecast period as well owing to increasing research & development activities by major companies.
Europe accounted for a significant share in global market revenue owing to growing geriatric population, which increases susceptibility towards various diseases, including glaucoma. Asia Pacific is expected to grow at an exponential rate during the forecast period due to rising incidences of open-angle glaucoma (OAG) and closed-angle glaucoma (CAG). In addition, improving healthcare infrastructure in emerging countries such as India and China will boost growth further.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The increasing prevalence of various eye diseases and disorders is one of the key growth drivers for the global Eye Stent market. According to a study by the World Health Organization (WHO), over 285 million people across the globe were affected by some form of visual impairment in 2015, out of which 246 million were cases of uncorrected refractive errors. This number is expected to increase in the coming years due to factors such as population growth, aging population, and changing lifestyles. This will create a high demand for Eye Stents, thereby driving market growth.
- Rising awareness about eye health: There has been a rising awareness about eye health in recent years among both healthcare professionals and patients alike. This has led to an increased demand for treatments such as Eye Stents, which can help improve vision quality and reduce associated risks.
- Technological advancements: The development of new technologies has helped drive market growth by offering innovative solutions that are more effective than traditional treatments methods used for various ocular conditions or diseases . For instance, Boston Scientific’s Lotus Edge stent features an asymmetric design that helps maintain lumen patency while minimizing compression on adjacent tissues during deployment . Such technological advancements are likely to fuel market growth in the coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Eye Stent Market Research Report
By Type
Polymer, Gelatin
By Application
Eye Clinics, Eye Research Institutes, Hospitals
By Companies
Glaukos, Innfocus, AqueSys Inc, ALLERGAN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Eye Stent Market Report Segments:
The global Eye Stent market is segmented on the basis of:
Types
Polymer, Gelatin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Eye Clinics, Eye Research Institutes, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Glaukos
- Innfocus
- AqueSys Inc
- ALLERGAN
Highlights of The Eye Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymer
- Gelatin
- By Application:
- Eye Clinics
- Eye Research Institutes
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eye Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An eye stent is a small, metal tube that is inserted into an individual's eye to help open up the pupil and allow better vision.
Some of the major companies in the eye stent market are Glaukos, Innfocus, AqueSys Inc, ALLERGAN.
The eye stent market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Eye Stent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Eye Stent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Eye Stent Market - Supply Chain
4.5. Global Eye Stent Market Forecast
4.5.1. Eye Stent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Eye Stent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Eye Stent Market Absolute $ Opportunity
5. Global Eye Stent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Eye Stent Market Size and Volume Forecast by Type
5.3.1. Polymer
5.3.2. Gelatin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Eye Stent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Eye Stent Market Size and Volume Forecast by Application
6.3.1. Eye Clinics
6.3.2. Eye Research Institutes
6.3.3. Hospitals
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Eye Stent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Eye Stent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Eye Stent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Eye Stent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Eye Stent Demand Share Forecast, 2019-2026
9. North America Eye Stent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Eye Stent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Eye Stent Market Size and Volume Forecast by Application
9.4.1. Eye Clinics
9.4.2. Eye Research Institutes
9.4.3. Hospitals
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Eye Stent Market Size and Volume Forecast by Type
9.7.1. Polymer
9.7.2. Gelatin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Eye Stent Demand Share Forecast, 2019-2026
10. Latin America Eye Stent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Eye Stent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Eye Stent Market Size and Volume Forecast by Application
10.4.1. Eye Clinics
10.4.2. Eye Research Institutes
10.4.3. Hospitals
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Eye Stent Market Size and Volume Forecast by Type
10.7.1. Polymer
10.7.2. Gelatin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Eye Stent Demand Share Forecast, 2019-2026
11. Europe Eye Stent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Eye Stent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Eye Stent Market Size and Volume Forecast by Application
11.4.1. Eye Clinics
11.4.2. Eye Research Institutes
11.4.3. Hospitals
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Eye Stent Market Size and Volume Forecast by Type
11.7.1. Polymer
11.7.2. Gelatin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Eye Stent Demand Share, 2019-2026
12. Asia Pacific Eye Stent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Eye Stent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Eye Stent Market Size and Volume Forecast by Application
12.4.1. Eye Clinics
12.4.2. Eye Research Institutes
12.4.3. Hospitals
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Eye Stent Market Size and Volume Forecast by Type
12.7.1. Polymer
12.7.2. Gelatin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Eye Stent Demand Share, 2019-2026
13. Middle East & Africa Eye Stent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Eye Stent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Eye Stent Market Size and Volume Forecast by Application
13.4.1. Eye Clinics
13.4.2. Eye Research Institutes
13.4.3. Hospitals
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Eye Stent Market Size and Volume Forecast by Type
13.7.1. Polymer
13.7.2. Gelatin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Eye Stent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Eye Stent Market: Market Share Analysis
14.2. Eye Stent Distributors and Customers
14.3. Eye Stent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Glaukos
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Innfocus
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AqueSys Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ALLERGAN
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook